KIMS to invest up to Rs 100 Cr more in subsidiary Sunshine Hospital

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+9.2%Reaction day

₹594.55

prior close

₹594.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+2.5%+6.6% vs market

Hospital peers, median of 23sector+1.6%+7.6% vs sector

On the reaction day the stock moved 6.6 pts more than Nifty Smallcap 250 and 7.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.5

15m

-0.2

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+9.2+2.5+6.6+1.6+7.6

Next day

+9.5+3.1+6.5+1.2+8.3

+15.5+3.2+12.4+4.4+11.2

+16.5+2.4+14.1+2.1+14.4

+14.4+0.8+13.6+1.7+12.7

+14.6+0.7+13.9+3.4+11.2

+17.5+2.0+15.5+6.4+11.2

15d

+21.0-1.8+22.8+4.0+17.0

+16.2-5.0+21.2-0.1+16.3

+11.2-2.3+13.5+0.1+11.0

+30.7+8.8+21.9+10.4+20.3

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KIMS board has approved investing up to Rs 100 Crore more in its material subsidiary Sarvejana Healthcare (Sunshine Hospital) in one or more tranches. KIMS currently holds 75.53 percent stake and will buy more shares from minority shareholders at value set by an independent valuer. Sunshine Hospital reported turnover of Rs 597 Cr in FY25 versus Rs 464.2 Cr in FY24. The all-cash deal aims to increase KIMS' strategic shareholding in the Hyderabad-based hospital.

Likely market impact

Slightly positive for KIMS shareholders as it boosts control over a fast-growing subsidiary, turnover up nearly 29 percent year on year, funded by cash.